Biocartis raises EUR 34.5 million in series D

Diagnostic company Biocartis S.A. (Lausanne, Switzerland) raised EUR 34.5 million ($44.5 million) in a series D round led by existing investor PMV. Existing investors RMM; Valiance; Debiopharm Group (Lausanne, Switzerland); Korys; Royal Philips Electronics N.V. (NYSE:PHG; Euronext:PHIA); Johnson & Johnson Development Corp.; Benaruca, the investment vehicle of Biocartis' founder Rudi Pauwels; New Rhein Healthcare; and an individual investor also participated. PMV's Roald Borre will join Biocartis' board. ...